- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Daehan New Pharm Co Ltd (054670)
Daehan New Pharm Co Ltd stock price live, this page displays KQ 054670 stock exchange data. View the 054670 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Daehan New Pharm Co Ltd real time stock price chart below.
What Is the Daehan New Pharm Co Ltd Stock Price Today?
The Daehan New Pharm Co Ltd stock price today is 7,250.
What Is the Stock Symbol for Daehan New Pharm Co Ltd?
The stock symbol for Daehan New Pharm Co Ltd is ""054670.""
What Stock Exchange Does Daehan New Pharm Co Ltd Trade On?
Daehan New Pharm Co Ltd is listed and trades on the KOSDAQ stock exchange.
Is Daehan New Pharm Co Ltd a Good Stock to Buy?
Determining whether Daehan New Pharm Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 054670 quote. (ISIN: KR7054670005)
What Is the Daehan New Pharm Co Ltd Stock Price Today?
The Daehan New Pharm Co Ltd stock price today is 7,250.
What Is the Stock Symbol for Daehan New Pharm Co Ltd?
The stock symbol for Daehan New Pharm Co Ltd is ""054670.""
What Stock Exchange Does Daehan New Pharm Co Ltd Trade On?
Daehan New Pharm Co Ltd is listed and trades on the KOSDAQ stock exchange.
Is Daehan New Pharm Co Ltd a Good Stock to Buy?
Determining whether Daehan New Pharm Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 054670 quote. (ISIN: KR7054670005)
KOSDAQ
Currency in KRW
7,250
+50(+0.69%)
Closed·
Fair Value
An estimate of a Daehan New Pharm's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7,150
7,260
52 wk Range
6,180
9,610
054670 Scorecard
Full Analysis
Trading at a low Price / Book multiple
054670 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Daehan New Pharm's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7,1507,260
52 wk Range
6,1809,610
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.38%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.38%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
054670 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Daehan New Pharm's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Daehan New Pharm Co Ltd Company Profile
Daehan Nupharm Co.,Ltd. manufactures and sells pharmaceuticals and veterinary products in South Korea and internationally. It offers pharmaceuticals drugs for cardiovascular, endocrine system, neuropsychiatric, gastrointestinal, respiratory system, antipyretic, analgesic, anti-inflammatory, anti-infective, musculoskeletal, osteoporosis, anti-cancer, urogenital system, antifungal, antiviral, hormones, dermatologic, central nervous system, anticonvulsive, amino acid, anesthetic, antiobesity, and others; vitamins; and inorganic products. The company also provides animal health and nutrition products; health supplements; and aesthetic/medical devices. The company was formerly known as Daehan New Pharm Co., Ltd and changed its name to Daehan Nupharm Co.,Ltd. in March 2025. Daehan Nupharm Co.,Ltd. was founded in 1984 and is headquartered in Hwaseong-si, South Korea.
Compare 054670 to Peers and Sector
Metrics to compare | 054670 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship054670PeersSector | |
|---|---|---|---|---|
P/E Ratio | 7.9x | 5.7x | −0.5x | |
PEG Ratio | −2.09 | 0.01 | 0.00 | |
Price/Book | 0.8x | 0.9x | 2.6x | |
Price / LTM Sales | 0.5x | 0.7x | 3.3x | |
Upside (Analyst Target) | - | 31.6% | 43.3% | |
Fair Value Upside | Unlock | 34.2% | 6.9% | Unlock |
Earnings
Latest Release
May 12, 2025
EPS / Forecast
183.68 / --
Revenue / Forecast
51.85B / --
FAQ
What Stock Exchange Does Daehan New Pharm Trade On?
Daehan New Pharm is listed and trades on the KOSDAQ stock exchange.
What Is the Stock Symbol for Daehan New Pharm?
The stock symbol for Daehan New Pharm is "054670."
What Is the Daehan New Pharm Market Cap?
As of today, Daehan New Pharm market cap is 101.76B.
What Is Daehan New Pharm's Earnings Per Share (TTM)?
The Daehan New Pharm EPS (TTM) is 914.02.
From a Technical Analysis Perspective, Is 054670 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Daehan New Pharm Stock Split?
Daehan New Pharm has split 1 times.
How Many Employees Does Daehan New Pharm Have?
Daehan New Pharm has 228 employees.
What is the current trading status of Daehan New Pharm (054670)?
As of 11 Aug 2025, Daehan New Pharm (054670) is trading at a price of 7,250.00, with a previous close of 7,200.00. The stock has fluctuated within a day range of 7,150.00 to 7,260.00, while its 52-week range spans from 6,180.00 to 9,610.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.